BRIDGER MANAGEMENT, LLC - Q3 2021 holdings

$855 Million is the total value of BRIDGER MANAGEMENT, LLC's 46 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 36.4% .

 Value Shares↓ Weighting
CZR SellCAESARS ENTERTAINMENT INC NE$62,389,000
-2.3%
555,653
-9.7%
7.30%
+22.5%
GDDY SellGODADDY INCcl a$52,788,000
-27.1%
757,353
-9.0%
6.18%
-8.6%
UBER  UBER TECHNOLOGIES INC$45,535,000
-10.6%
1,016,4090.0%5.33%
+12.1%
NTRA  NATERA INC$43,865,000
-1.8%
393,6200.0%5.13%
+23.0%
CNC BuyCENTENE CORP DEL$40,664,000
-11.6%
652,600
+3.5%
4.76%
+10.9%
MS SellMORGAN STANLEY$40,519,000
-24.3%
416,392
-28.7%
4.74%
-5.1%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$38,313,000
-3.4%
52,659
-4.2%
4.48%
+21.2%
ROST SellROSS STORES INC$37,953,000
-20.3%
348,668
-9.2%
4.44%
-0.0%
CLVT BuyCLARIVATE PLC$35,026,000
+4.3%
1,599,380
+31.1%
4.10%
+30.8%
POST SellPOST HLDGS INC$34,160,000
-35.6%
310,098
-36.6%
4.00%
-19.3%
VRSN SellVERISIGN INC$32,538,000
-25.7%
158,714
-17.4%
3.81%
-6.8%
SHC SellSOTERA HEALTH CO$29,127,000
-20.2%
1,113,826
-26.1%
3.41%
+0.1%
ALC SellALCON AG$28,673,000
-41.8%
356,315
-49.2%
3.36%
-27.0%
LKQ SellLKQ CORP$25,255,000
-37.3%
501,887
-38.7%
2.96%
-21.4%
FTDR  FRONTDOOR INC$25,004,000
-15.9%
596,7580.0%2.93%
+5.4%
GDS  GDS HLDGS LTDsponsored ads$22,362,000
-27.9%
395,0250.0%2.62%
-9.6%
ETSY  ETSY INC$20,331,000
+1.0%
97,7630.0%2.38%
+26.7%
SKIN NewTHE BEAUTY HEALTH COMPANY$19,480,000750,100
+100.0%
2.28%
MSGS NewMADISON SQUARE GRDN SPRT CORcl a$17,795,00095,700
+100.0%
2.08%
ATRA SellATARA BIOTHERAPEUTICS INC$16,586,000
-19.5%
926,588
-30.1%
1.94%
+0.9%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$14,610,000
-1.6%
1,500,0000.0%1.71%
+23.3%
PVG  PRETIUM RES INC$13,558,000
+0.8%
1,406,4120.0%1.59%
+26.4%
DG NewDOLLAR GEN CORP NEW$12,919,00060,900
+100.0%
1.51%
IRWD SellIRONWOOD PHARMACEUTICALS INC$12,675,000
-51.6%
970,514
-52.3%
1.48%
-39.3%
PSPCU  POST HOLDINGS PARTNERING CORunit 99/99/9999$12,638,000
-2.7%
1,250,0000.0%1.48%
+22.0%
HCA SellHCA HEALTHCARE INC$12,552,000
-11.5%
51,713
-24.6%
1.47%
+11.0%
ALNY SellALNYLAM PHARMACEUTICALS INC$11,292,000
-40.2%
59,804
-46.3%
1.32%
-25.0%
ZGNX SellZOGENIX INC$11,125,000
-32.2%
732,413
-22.9%
1.30%
-15.0%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$10,100,000
-1.3%
1,000,0000.0%1.18%
+23.8%
LIVN  LIVANOVA PLC$10,025,000
-5.9%
126,6000.0%1.17%
+18.0%
AMWL SellAMERICAN WELL CORPcl a$9,530,000
-45.2%
1,046,117
-24.4%
1.12%
-31.3%
NewWILLIAMS ROWLAND ACQUISITION$9,415,000950,000
+100.0%
1.10%
CUTR SellCUTERA INC$7,341,000
-54.0%
157,522
-51.6%
0.86%
-42.3%
QTRX BuyQUANTERIX CORP$7,188,000
-4.1%
144,359
+13.0%
0.84%
+20.3%
NEXI  NEXIMMUNE INC$6,056,000
-7.2%
400,0000.0%0.71%
+16.4%
TGTX SellTG THERAPEUTICS INC$4,726,000
-44.4%
141,997
-35.2%
0.55%
-30.4%
DXCM SellDEXCOM INC$4,294,000
-54.2%
7,853
-64.2%
0.50%
-42.6%
NewSURROZEN INC$4,193,000700,001
+100.0%
0.49%
SEER BuySEER INC$3,754,000
+98.5%
108,719
+88.4%
0.44%
+149.4%
TECH NewBIO-TECHNE CORP$3,484,0007,190
+100.0%
0.41%
ABCM NewABCAM PLCads$2,105,000103,850
+100.0%
0.25%
OLK  OLINK HLDG ABsponsored ads$1,114,000
-29.5%
45,9250.0%0.13%
-12.2%
NAUT BuyNAUTILUS BIOTECHNOLOGY INC$774,000
+34.4%
126,000
+121.1%
0.09%
+68.5%
NewSURROZEN INC*w exp 08/01/203$490,000466,666
+100.0%
0.06%
NewWILLIAMS ROWLAND ACQUISITION*w exp 12/11/202$238,000475,000
+100.0%
0.03%
MYPSW  PLAYSTUDIOS INC*w exp 06/17/202$109,000
-58.2%
141,1050.0%0.01%
-45.8%
ALEC ExitALECTOR INC$0-203,900
-100.0%
-0.40%
CHFWU ExitCONSONANCE HFW ACQUISITION Cunit 99/99/9999$0-700,000
-100.0%
-0.68%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-116,015
-100.0%
-0.68%
ZBH ExitZIMMER BIOMET HOLDINGS INC$0-74,670
-100.0%
-1.12%
NVRO ExitNEVRO CORP$0-87,200
-100.0%
-1.35%
LBRDA ExitLIBERTY BROADBAND CORP$0-87,833
-100.0%
-1.38%
PODD ExitINSULET CORP$0-100,145
-100.0%
-2.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (854664000.0 != 854668000.0)

Export BRIDGER MANAGEMENT, LLC's holdings